CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for BioPlus Acquisition Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

BioPlus Acquisition Corp
260 Madison Avenue, Suite 800
NEW YORK, NY  10016  United States

This company ceased filing statements with the SEC on 10/16/2023.
On 10/4/2023, the Company announced it would not consummate a business combination and intends to liquidate as soon as practicable
This company is no longer actively traded on any major stock exchange.

Business Summary
BioPlus Acquisition Corp. is a blank check company. The Company is formed for the purpose effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target and has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. The Company intends to focus its search on companies in the life sciences industry. The Company has not commenced any operations nor generated any revenue.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/202312/31/2022YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman, Chief Business Officer JonathanRigby 54
Chief Executive Officer, Chief Financial Officer, Director RossHaghighat 58
Independent Vice Chairman of the Board RonaldEastman 69
4 additional Officers and Directors records available in full report.

General Information
Number of Employees: 2 (As of 12/31/2021)
Outstanding Shares: 25,117,477 (As of 8/14/2023)
Shareholders: 4
Stock Exchange: NASD
Federal Tax Id: 981583272


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, November 7, 2024